Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

45
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
45
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

17
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
17
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pixel-Level RGBT Fusion Tracking via Heterogeneous Multi-Expert Distillation and Decoupled Representation Learning.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

Exploration of the Clinical Assessment and Prognostic Value of Society for Cardiovascular Angiography and Intervention Shock Staging in Patients With Acute Myocardial Infarction and Cardiogenic Shock on Veno-arterial Extracorporeal Membrane Oxygenation Support.

Reviews in cardiovascular medicine·2026
Same author

Unveiling the Power of Multi-Modal Template Update in RGBT Tracking.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026
Same author

ECMO management in cardiogenic shock-specialized versus non-cardiogenic shock-specialized centers: a registry-based analysis.

BMC anesthesiology·2025
Same author

Clinical study of area-decreasing technique and conventional post-closure technique for V-A ECMO weaning application: study protocol of a randomised controlled trial.

BMJ open·2025
Same author

AFTER: Attention-Based Fusion Router for RGBT Tracking.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2025

相关实验视频

Updated: Sep 10, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K

在复杂高风险PCI期间的预防VA-ECMO:随机对照试验

Chenliang Pan1, Youqi Zhu1, Jing Zhao1

  • 1The First School of Clinical Medicine of Lanzhou University, Lanzhou, China; Heart Center, The First Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Cardiovascular Diseases, Lanzhou, China.

JACC. Advances
|August 22, 2025
PubMed
概括

在高风险的穿皮冠状动脉干预 (PCI) 中,预防性静脉外膜氧化 (VA- ECMO) 显著减少了危及生命的并发症和改善了结局. 这种方法为复杂的PCI患者提供了更安全的策略.

关键词:
复杂的高风险冠状动脉干预有效性主要心血管和脑血管不良事件安全性静脉外体膜氧化

更多相关视频

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

430
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

相关实验视频

Last Updated: Sep 10, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.4K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

430
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

科学领域:

  • 心血管医学
  • 干预心脏病学
  • 危急护理医学

背景情况:

  • 在高风险的穿皮冠状动脉干预 (PCI) 中,存在有限的预防性静脉外膜氧化 (VA- ECMO) 证据.
  • 患有复杂冠状动脉病变的患者经常面临重大程序风险.

研究的目的:

  • 在选择性PCI期间评估预防VA-ECMO的安全性和有效性.
  • 在接受PCI或不接受预防VA- ECMO的患者中比较并发症率和SYNTAX得分降低.

主要方法:

  • 一个单中心随机试验,涉及70名患有高风险冠状动脉病变 (SYNTAX评分≥33) 的患者,这些患者拒绝了绕道手术.
  • 在PCI之前,患者被分配到预防性VA- ECMO (n=34) 或对照组 (n=36).
  • 主要终点包括PCI后的并发症率和SYNTAX得分降低.

主要成果:

  • 预防性VA- ECMO组的生命危险并发症发生率显著降低 (0%对19. 4%,P=0. 01).
  • 在19%的对照组中需要紧急VA-ECMO.
  • 在VA- ECMO组中,SYNTAX评分的绝对降低幅度更大 (27. 2对22. 5,P=0. 04).

结论:

  • 在高风险的PCI中,预防VA-ECMO与危及生命的并发症的减少有关.
  • 这一策略还使冠状动脉病变复杂性通过SYNTAX得分得到更显著的降低.
  • 需要进一步的大规模研究来证实这些发现并优化管理策略.